Species differences in [11C]clorgyline binding in brain

Nucl Med Biol. 2001 Oct;28(7):779-85. doi: 10.1016/s0969-8051(01)00245-1.

Abstract

[11C]Clorgyline selectively binds to MAO A in the human brain. This contrasts with a recent report that [11C]clorgyline (in contrast to other labeled MAO A inhibitors) is not retained in the rhesus monkey brain [4]. To explore this difference, we compared [11C]clorgyline in the baboon brain before and after clorgyline pretreatment and we also synthesized deuterium substituted [11C]clorgyline (and its nor-precursor) for comparison. [11C]Clorgyline was not retained in the baboon brain nor was it influenced by clorgyline pretreatment or by deuterium substitution, contrasting to results in humans. This suggests a species difference in the susceptibility of MAO A to inhibition by clorgyline and represents an unusual example of where the behavior of a radiotracer in the baboon brain does not predict its behavior in the human brain.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain / diagnostic imaging
  • Brain / enzymology
  • Brain / metabolism*
  • Carbon Radioisotopes / pharmacokinetics
  • Clorgyline / analogs & derivatives
  • Clorgyline / pharmacokinetics*
  • Deuterium
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Indicators and Reagents
  • Isotope Labeling
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / pharmacokinetics*
  • Papio
  • Radiopharmaceuticals / chemical synthesis
  • Radiopharmaceuticals / pharmacokinetics*
  • Species Specificity
  • Tomography, Emission-Computed

Substances

  • Carbon Radioisotopes
  • Indicators and Reagents
  • Monoamine Oxidase Inhibitors
  • Radiopharmaceuticals
  • Deuterium
  • Monoamine Oxidase
  • Clorgyline